Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL051723-03
Application #
2228632
Study Section
Special Emphasis Panel (ZHL1-CSR-S (S2))
Project Start
1993-12-01
Project End
1997-11-30
Budget Start
1995-12-01
Budget End
1996-11-30
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Oregon Regional Primate Research Center
Department
Type
DUNS #
City
Beaverton
State
OR
Country
United States
Zip Code
97006
Minshall, Richard D; Pavcnik, Dusan; Browne, David L et al. (2002) Nongenomic vasodilator action of progesterone on primate coronary arteries. J Appl Physiol 92:701-8
Minshall, R D; Pavcnik, D; Halushka, P V et al. (2001) Progesterone regulation of vascular thromboxane A(2) receptors in rhesus monkeys. Am J Physiol Heart Circ Physiol 281:H1498-507
Minshall, R D; Miyagawa, K; Chadwick, C C et al. (1998) In vitro modulation of primate coronary vascular muscle cell reactivity by ovarian steroid hormones. FASEB J 12:1419-29
Minshall, R D; Stanczyk, F Z; Miyagawa, K et al. (1998) Ovarian steroid protection against coronary artery hyperreactivity in rhesus monkeys. J Clin Endocrinol Metab 83:649-59
Hermsmeyer, K (1998) Role of T channels in cardiovascular function. Cardiology 89 Suppl 1:2-9
Hermsmeyer, K; Miyagawa, K; Kelley, S T et al. (1997) Reactivity-based coronary vasospasm independent of atherosclerosis in rhesus monkeys. J Am Coll Cardiol 29:671-80
Miyagawa, K; Rosch, J; Stanczyk, F et al. (1997) Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm. Nat Med 3:324-7
Miyagawa, K; Vidgoff, J; Hermsmeyer, K (1997) Ca2+ release mechanism of primate drug-induced coronary vasospasm. Am J Physiol 272:H2645-54
Hermsmeyer, K; Miyagawa, K (1996) Protein kinase C mechanism enhances vascular muscle relaxation by the Ca2+ antagonist, Ro 40-5967. J Vasc Res 33:71-7
Eberhard, M; Miyagawa, K; Hermsmeyer, K et al. (1995) Effects of mibefradil on intracellular Ca2+ release in cultured rat cardiac fibroblasts and human platelets. Naunyn Schmiedebergs Arch Pharmacol 353:94-101